Berthet S, Olivier P, Montastruc JL, Lapeyre-Mestre M. Drug safety of rosiglitazone and pioglitazone in France : a study using the French PharmacoVigilance database. BMC Clin Pharmacol 2011, 11, 5.

Bismuth M, Oustric S, Boyer P, Escourrou B, Brillac T, Mesthe P, Boutin A, Arlet P, Montastruc JL. La pharmacie familiale : enquête auprès d’un échantillon de patients en Midi-Pyrénées. Thérapie 2011, 66, 131-134.

Bismuth S, Laing-Leng E, Oustric S, Montastruc JL, Lapeyre-Mestre M. Quels antalgiques après le retrait du dextropropoxyphène ? Enquête auprès de médecins généralistes de la région Midi-Pyrénées. Thérapie 2011, 66, 25-28.

Bœuf-Cazou O, Lapeyre-Mestre M, Niezborala M, Montastruc JL. Profil de consommation de substances psychoactives dans le milieu du travail : résultats de l’enquête "mode de vie et travail". Thérapie 2011, 66, 155-165.

Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL. Drug-induced parkinsonism : a review of 17 years experience in a regional pharmacovigilance center in France. Mov Disord 2011, 12, 2226-31.

Bondon-Guitton E, Prévot G, Didier A, Montastruc JL. Pulmonary arterial hypertension and benfluorex : 5 case reports. Thérapie 2011, 66, 135-136.

Caillet C, Durrieu G, Jacquet A, Faucher A, Ouaret S, Perrault-Pochat MC, Kreft-jais C, Castot A, Montastruc JL and French Network of PharmacoVigilance Centres (CRPV) : Autret-Leca E, Baldin B, Bavoux F, Bénard-laribière A, Biour M, Beyens MN, Colin F, Coquerel A, Crepin S, Décréau-Gaillon G, Dos Santos S, Efthekhari P, Favrelière S, Gautier S, Gras-Champel V, Javot L, Jean-Pastor MJ, Le Beller C, Lebrun-Vignes B, Millaret A, Perrazi A, Pinzani V, Riché C, Schir E, Sgro C, Tebacher-Alt M, Trenque T, Valnet-Rabier MB, Veyrac G . Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France. Eur J Clin Pharmacol 2011, 67, 649-651.

Crespin S, Bourrel R, Hurault-Delarue C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Drug prescribing before and during pregnancy in south west France. Drug Saf 2011, 34, 595-604.

Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine : multinational case-control study in Europe. Br Med J 2011,343, d3908.

Droz-Perroteau C, Dureau-Pournin C, Vespignani H, Marchal C, Blin P, Blazejewski S, Pollet C, Jové J, Robinson P, Moore N, Fourrier-Réglat A, on behalf of the EULEV study group (Vespignani H, Marchal C, Alpérovitch A, Bénichou J, Jager A, Lavernhe G, Mann M, Montastruc JL, Pédespan JM). The EULEV cohort study : rates of and factors associated with continuation of levetiracetam after 1 year. Br J Clin Pharmacol 2011, 1, 121-7.

Duhalde V, Delarue C, Lacroix I, Suarez C, Bourrel R, Montastruc JL, Damase-Michel C. Antihypertensive drug prescription pattern before and during pregnancy in France. Pregnancy hypertension : An International Journal of Women’s Cardiovascular Health 2011, 185-189.

Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jais C, Castot A, Damase-Michel C, Montastruc JL, et le Réseau Français des centres de pharmacovigilance. Campagne nationale de vaccination contre la grippe A (H1N1)v : suivi national de pharmacovigilance. Thérapie 2011, 66, 527-40.

Fuzier R, Bataille B, Fuzier V, Richez AS, Maguès JP, Choquet O, Montastruc JL, Lapeyre-Mestre M. Spinal anesthesia failure after local anesthetic injection into cerebrospinal fluid. Regional Anesth and Pain Med 2011, 36, 322-26.

Grossac J, Ruiz S, Bondon-Guitton E, Roux FE, Fourcade O, Montastruc JL, Geeraerts T. Severe intracranial bleeding related to vitamin K Antagonist-Ropinirole interaction. Mov Disord. 2011, 26, 1962-63.

Hillaire-Buys D, Faillie JL, Montastruc JL. Pioglitazone and bladder cancer. Lancet 2011, 378, 1543-4.

Hurault-Delarue C, Lacroix I, Vidal S, Montastruc JL, Damase-Michel C. Drugs in pregnancy : study in the EFEMERIS database (2004 to 2008). Gynecol Obstet Fertil 2011, 10, 554-8.

Jegu J, Gallini A, Soler P, Montastruc JL, Lapeyre-Mestre M. Slow-release oral morphine for opioid maintenance treatment : a systematic review. Br J Clin Pharmacol 2011, 71, 832-843.

Lacroix I, Berrebi A, Garipuy D, Schmitt L, Hammou Y, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Buprenorphine versus methadone in pregnant opioid-dependent women : a prospective multicenter study. Eur J Clin Pharmacol. 2011, 67, 1053-59.

Lacroix I, Damase-Michel C, Kreft-Jais C, Castot A, Montastruc JL. 2009 H1N1 influenza vaccines in pregnant women : the French Pharmacovigilance survey. Vaccine 2011, 7, 1357-8.

Lacroix I, Hurault-Delarue C, Kessler S, Guitard C, Vidal S, Albouy-Cossard C, Montastruc JL, Damase-Michel C. First epidemiologic data about phloroglucinol exposure during first trimester of pregnancy. Gynecol Obstet Fertil 2011, 39, 694-697.

Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Mirmohamde M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BHC, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe’er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK for the Spanish DILI Registry, EUDRAGENE, DILIN, DILIGEN, and international SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011, 141, 338-47.

Montastruc JL, Durrieu G, Rascol O. Pandemrix°, (H1N1)v influenza and reported cases of narcolepsy. Vaccine 2011, 29, 2011.

Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and Strengths of the disproportionality analysis for identification of Adverse Drug Reactions in a PharmacoVigilance database. Br J Clin Pharmacol. 2011, 72, 905-908.

Noize P, Bagheri H, Durrieu G, Haramburu F, Moore N, Giraud P, Galinier M, Pourrat J, Montastruc JL. Life-threatening drug-associated hyperkalemia : a retrospective study from laboratory signals. Pharmacoepidemiol Drug Saf 2011, 20,747-753.

Omon E, Damase-Michel C, Hurault-Delarue C, Lacroix I, Montastruc JL, Oustric S, Escourrou B. Non-adjuvanted 2009 influenza A (H1N1)v vaccine pregnant women : the results of a French prospective descriptive study. Vaccine 2011, 29, 9649-54.

Orriols L, Philip P, Moore N, Castot A, Gadegbeku B, Delorme B, Mallaret M, Lagarde E ; on behalf of the CESIR Research Group : Avalos M, Bazin F, Blazejewski S, Contrand B, Durrieu G, Girodet PO, Goldberg M, Laumon B, Lauque D, Lecoules N, Memes L, Merle L, Merlière Y, Montastruc JL, Noize P, Orsoni N, POariente A, Ribéreau-Gayon R, Salmi LR, Thiessard F, Tricotel A. Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther 2011, 89, 595-601.

Perrin-Terrin A, Pathak A, Lapeyre-Mestre M. QT interval prolongation : prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundam Clin Pharmacol. 2011 Aug ;25(4):503-10.

Rouve N, Bagheri H, Telmon N, Pathak A, Franchitto N, Schmitt L, Rougé D, Lapeyre-Mestre M, Montastruc JL ; the French Association of Regional PharmacoVigilance Centres. Prescribed drugs and violence : a case/noncase study in the French PharmacoVigilance Database. Eur J Clin Pharmacol. 2011, 67, 1189-98.

Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Puechal X, Wendling D, Lemann M, Ravaud P, Mariette X, Bagheri H, Blandin B, Breban M, Bretagne S, Castot A, Chichmanian RM, Chosidow O, Dautzenberg B, Dellamonica P, Dufeu-Demazes N, Emilie D, Gillet C, Hugot JP,Kreft Jais C, Leport C, Montastruc JL, Prieur AM, Ravaud P, Roux C, Vittecoq D. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective french RATIO registry. Ann Rheum Dis 2011, 70, 616.

Wagner S, Varet-Legros M, Fabre C, Montastruc JL, Bagheri H. Confounding factors for variation of clozapine plasma levels : drug interactions with proton pump inhibitor or infectious aetiologies ? Eur J Clin Pharmacol 2011, 67, 533-534.